Chiome Bioscience Inc
TSE:4583
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chiome Bioscience Inc
TSE:4583
|
JP |
Intrinsic Value
The intrinsic value of Chiome Bioscience Inc (4583) under the Base Case is 66.11 JPY per share. Compared with the current market price of 92 JPY, the stock appears Overvalued by 28% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Chiome Bioscience Does
Chiome Bioscience is a biotechnology company that discovers and develops antibody drugs. It uses its own antibody discovery technology to find drug candidates that can bind to disease targets, then advances the most promising ones through preclinical and early clinical development. The company is focused on medicines built around antibodies, which are designed to be precise and easier to engineer than many traditional drugs.
- Headquarters
- Japan JP
- Employees
- 49
- IPO date
- Dec 20, 2011
Revenue & Expenses Breakdown
Chiome Bioscience Inc
Earnings Waterfall
Chiome Bioscience Inc
The intrinsic value for Chiome Bioscience Inc (4583) under the Base Case is 66.11 JPY.
Compared with the current market price of 92 JPY, the stock appears Overvalued by 28% .